Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

First MRI With New Cochlear Implant With Rotatable Internal Magnet System and Proposal for Standardization of Reporting Magnet-Related Artifact Size.

Cass ND, Honce JM, O'Dell AL, Gubbels SP.

Otol Neurotol. 2019 Aug;40(7):883-891. doi: 10.1097/MAO.0000000000002269.

PMID:
31219967
2.

Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes.

Kletenik I, Alvarez E, Honce JM, Valdez B, Vollmer TL, Medina LD.

Mult Scler J Exp Transl Clin. 2019 Feb 13;5(1):2055217319827618. doi: 10.1177/2055217319827618. eCollection 2019 Jan-Mar.

3.

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.

Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL.

Neurology. 2019 Feb 12;92(7):e723-e732. doi: 10.1212/WNL.0000000000006916. Epub 2019 Jan 11.

PMID:
30635477
4.

Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.

Sakamoto MR, Honce JM, Lindquist DL, Camidge DR.

Clin Lung Cancer. 2019 Mar;20(2):e133-e136. doi: 10.1016/j.cllc.2018.11.010. Epub 2018 Nov 29. No abstract available.

PMID:
30578110
5.

Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [18F]-Fluorodeoxyglucose Positron Emission Tomography Study.

Kindred JH, Honce JM, Kwak JJ, Rudroff T.

Cannabis Cannabinoid Res. 2018 Oct 13;3(1):213-218. doi: 10.1089/can.2018.0019. eCollection 2018.

6.

Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure.

Berman BD, Honce JM, Shelton E, Sillau SH, Nagae LM.

Neuroimage Clin. 2018 Jun 5;19:805-812. doi: 10.1016/j.nicl.2018.06.004. eCollection 2018.

7.

The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.

Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E.

J Neurol Sci. 2018 Jul 15;390:89-93. doi: 10.1016/j.jns.2018.04.021. Epub 2018 Apr 13.

PMID:
29801915
8.

PRES: Review of Histological Features.

Willard N, Honce JM, Kleinschmidt-DeMasters BK.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):100-118. doi: 10.1093/jnen/nlx112. Review.

PMID:
29325172
9.

Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.

Kindred JH, Li K, Ketelhut NB, Proessl F, Fling BW, Honce JM, Shaffer WR, Rudroff T.

Complement Ther Med. 2017 Aug;33:99-104. doi: 10.1016/j.ctim.2017.07.002. Epub 2017 Jul 10.

PMID:
28735833
10.

Cannabis and Multiple Sclerosis-The Way Forward.

Rudroff T, Honce JM.

Front Neurol. 2017 Jun 23;8:299. doi: 10.3389/fneur.2017.00299. eCollection 2017. No abstract available.

11.

The Addition of Endovascular Intervention for Dural Venous Sinus Thrombosis: Single-Center Experience and Review of Literature.

Nyberg EM, Case D, Nagae LM, Honce JM, Reyenga W, Seinfeld J, Poisson S, Leppert MH.

J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2240-2247. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.006. Epub 2017 Jun 9. Review.

PMID:
28606660
12.

Imaging of Laser Therapy in Epilepsy.

Nagae LM, Honce JM, Nyberg E, Ojemann S, Abosch A, Drees CN.

J Neuroimaging. 2017 May;27(3):292-299. doi: 10.1111/jon.12438. Epub 2017 Mar 29.

PMID:
28370739
13.

Diagnostic, treatment, and surgical imaging in epilepsy.

Nagae LM, Lall N, Dahmoush H, Nyberg E, Mirsky D, Drees C, Honce JM.

Clin Imaging. 2016 Jul-Aug;40(4):624-36. doi: 10.1016/j.clinimag.2016.02.012. Epub 2016 Feb 16. Review.

PMID:
27317207
14.

Neuroimaging of Concussion.

Honce JM, Nyberg E, Jones I, Nagae L.

Phys Med Rehabil Clin N Am. 2016 May;27(2):411-28. doi: 10.1016/j.pmr.2016.01.002. Review.

PMID:
27154853
15.

Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes.

Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD.

Front Neuroanat. 2016 Feb 23;10:17. doi: 10.3389/fnana.2016.00017. eCollection 2016.

16.

Remyelination Therapy in Multiple Sclerosis.

Harlow DE, Honce JM, Miravalle AA.

Front Neurol. 2015 Dec 10;6:257. doi: 10.3389/fneur.2015.00257. eCollection 2015. Review.

17.

Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.

Honce JM, Nagae L, Nyberg E.

Mult Scler Int. 2015;2015:809252. doi: 10.1155/2015/809252. Epub 2015 Sep 21. Review.

18.

Sex Differences in Gray Matter Changes and Brain-Behavior Relationships in Patients with Stimulant Dependence.

Regner MF, Dalwani M, Yamamoto D, Perry RI, Sakai JT, Honce JM, Tanabe J.

Radiology. 2015 Dec;277(3):801-12. doi: 10.1148/radiol.2015142541. Epub 2015 Jul 14.

19.

Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes.

Nyberg EM, Tanabe J, Honce JM, Krmpotich T, Shelton E, Hedeman J, Berman BD.

Parkinsonism Relat Disord. 2015 May;21(5):536-40. doi: 10.1016/j.parkreldis.2015.03.008. Epub 2015 Mar 13.

20.

Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Weisfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD.

Brain. 2015 Mar;138(Pt 3):517-39. doi: 10.1093/brain/awu397. Epub 2015 Jan 29. Review.

21.

Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.

Honce JM.

Mult Scler Int. 2013;2013:627870. doi: 10.1155/2013/627870. Epub 2013 Jun 25.

Supplemental Content

Loading ...
Support Center